Peri-Implant Tissues

2

Review clinical trials related to Peri-Implant Tissues. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Volumetric Analysis of Peri-Implant Soft Tissue Changes Between Polyethereketone(PEEK) Anatomic Healing Abutments and Standard Healing Abutments in Posterior Single Implant Restorations

This prospective randomized clinical trial will evaluate the clinical outcomes of the implant crown fabricated with standard scan body (control) and polyetheretherketone (PEEK) anatomic healing abutment (test).

Participants needed: 38
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: DR NUR HAFIZAH KAMAR AFFENDIUpdated: Jun 3, 2026Locations: 1
Eligibility criteria

Subjects of either sex or aged 18 above [+6]

Presence of active acute infection [+7]

Status: Recruiting

The Effect of Injectable Platelet-Rich Fibrin in Peri-implant Soft Tissue

An inadequate amount of peri-implant soft tissue results in more plaque accumulation around the implants, peri-implant mucositis, marginal bone loss, mucosal recession, and/or attachment loss. In the literature, there are studies evaluating the application of injectable platelet-rich fibrin to the gingiva and oral mucosa around teeth, but injectable platelet-rich fibrin application around implants has not been encountered. This study aimed to evaluate the effect of subgingival and submucosal application of injectable platelet-rich fibrin on peri-implant soft tissue phenotype in patients with inadequate peri-implant soft tissue phenotype.The study will include 80 systemically healthy and non-smoking patients/implants older than 18 years of age with insufficient peri-implant keratinized mucosa width and mucosal thickness who applied to Kütahya University of Health Sciences, Faculty of Dentistry, Department of Periodontology. There are two study groups according to peri-implant mucosa phenotype: Thin phenotype and thick phenotype. All patients will undergo the same procedure of injectable platelet-rich fibrin application

Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Kutahya Health Sciences UniversityUpdated: Sep 11, 2025Locations: 1
Eligibility criteria

be over 18 years old [+4]

Being out of the defined age group [+6]